BR0016052A - Processo para a preparação de cloridrato de epinastina na modificação de cristal de elevado ponto de fusão - Google Patents

Processo para a preparação de cloridrato de epinastina na modificação de cristal de elevado ponto de fusão

Info

Publication number
BR0016052A
BR0016052A BR0016052-0A BR0016052A BR0016052A BR 0016052 A BR0016052 A BR 0016052A BR 0016052 A BR0016052 A BR 0016052A BR 0016052 A BR0016052 A BR 0016052A
Authority
BR
Brazil
Prior art keywords
preparation
melting point
modification
high melting
epinastine hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
BR0016052-0A
Other languages
English (en)
Inventor
Rolf Dach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH Co KG filed Critical Boehringer Ingelheim Pharma GmbH Co KG
Publication of BR0016052A publication Critical patent/BR0016052A/pt
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE CLORIDRATO DE EPINASTINA NA MODIFICAçãO DE CRISTAL DE ELEVADO PONTO DE FUSãO". A invenção refere-se a um processo para a preparação de cloridrato de epinastina na modificação cristalina com elevado ponto de fusão.
BR0016052-0A 1999-12-03 2000-11-29 Processo para a preparação de cloridrato de epinastina na modificação de cristal de elevado ponto de fusão Pending BR0016052A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19958460A DE19958460A1 (de) 1999-12-03 1999-12-03 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation
PCT/EP2000/011942 WO2001040229A2 (de) 1999-12-03 2000-11-29 Verfahren zur herstellung von epinastine-hydrochlorid in der hochschmelzenden kristallmodifikation

Publications (1)

Publication Number Publication Date
BR0016052A true BR0016052A (pt) 2002-07-23

Family

ID=7931396

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016052-0A Pending BR0016052A (pt) 1999-12-03 2000-11-29 Processo para a preparação de cloridrato de epinastina na modificação de cristal de elevado ponto de fusão

Country Status (23)

Country Link
US (1) US6403790B1 (pt)
EP (1) EP1237892B1 (pt)
JP (1) JP4789383B2 (pt)
KR (1) KR100737191B1 (pt)
CN (1) CN1402728A (pt)
AR (1) AR026678A1 (pt)
AT (1) ATE238306T1 (pt)
AU (1) AU2163501A (pt)
BR (1) BR0016052A (pt)
CA (1) CA2389170C (pt)
CO (1) CO5251470A1 (pt)
CZ (1) CZ20021843A3 (pt)
DE (2) DE19958460A1 (pt)
DK (1) DK1237892T3 (pt)
EA (1) EA200200630A1 (pt)
ES (1) ES2198368T3 (pt)
HU (1) HUP0203501A2 (pt)
IL (1) IL149711A0 (pt)
MX (1) MXPA02005330A (pt)
PL (1) PL355628A1 (pt)
PT (1) PT1237892E (pt)
UY (1) UY26461A1 (pt)
WO (1) WO2001040229A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
JP4298212B2 (ja) * 2002-03-29 2009-07-15 大日本印刷株式会社 塩酸エピナスチン高融点型結晶の製造法
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
KR101386530B1 (ko) 2006-12-29 2014-04-18 케이피엑스 라이프사이언스 주식회사 순도 및 수율이 향상된3-아미노-9,13ｂ디하이드로-1Ｈ-디벤즈-[ｃ,ｆ]이미다조[1,5-ａ]-아제핀 염산염의 제조방법
CN104098575B (zh) * 2013-04-15 2016-06-01 四川科瑞德凯华制药有限公司 一种盐酸依匹斯汀晶型及其制备方法和用途
CN115448927A (zh) * 2022-10-20 2022-12-09 重庆瑞泊莱医药科技有限公司 一种氢溴酸依匹斯汀晶型ii及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE4102148A1 (de) * 1991-01-25 1992-07-30 Boehringer Ingelheim Kg Verfahren zur herstellung von 3-amino-9,13b-dihydro-1h-dibenz-(c,f)imidazol(1,5-a)azepin-hydrochlorid
JP3726291B2 (ja) * 1993-07-05 2005-12-14 三菱ウェルファーマ株式会社 安定な結晶構造を有するベンゾオキサジン化合物およびその製造法
JPH083160A (ja) * 1994-06-22 1996-01-09 Nippon Kayaku Co Ltd ６−（１−ｈ−イミダゾール−１−イル）−７−ニトロ−２，３−（１ｈ，４ｈ）−キノキサリンジオン塩酸塩又は硫酸塩の分離精製法
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
JPH0948765A (ja) * 1995-08-04 1997-02-18 Toyama Chem Co Ltd 安定な結晶構造を有するトリアゾール誘導体およびその製造法
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne

Also Published As

Publication number Publication date
KR100737191B1 (ko) 2007-07-10
UY26461A1 (es) 2001-07-31
AR026678A1 (es) 2003-02-19
DK1237892T3 (da) 2003-08-04
ATE238306T1 (de) 2003-05-15
CZ20021843A3 (cs) 2002-08-14
KR20020058080A (ko) 2002-07-12
WO2001040229A2 (de) 2001-06-07
EP1237892B1 (de) 2003-04-23
DE19958460A1 (de) 2001-06-07
JP2003515536A (ja) 2003-05-07
DE50001920D1 (de) 2003-05-28
EA200200630A1 (ru) 2002-12-26
US6403790B1 (en) 2002-06-11
ES2198368T3 (es) 2004-02-01
CA2389170A1 (en) 2001-06-07
WO2001040229A3 (de) 2001-12-06
JP4789383B2 (ja) 2011-10-12
CA2389170C (en) 2008-01-08
PT1237892E (pt) 2003-08-29
MXPA02005330A (es) 2003-01-28
EP1237892A2 (de) 2002-09-11
AU2163501A (en) 2001-06-12
CO5251470A1 (es) 2003-02-28
IL149711A0 (en) 2002-11-10
HUP0203501A2 (hu) 2003-03-28
PL355628A1 (en) 2004-05-04
CN1402728A (zh) 2003-03-12

Similar Documents

Publication Publication Date Title
BR0116444A (pt) Processo para a preparação de brometo de tiotrópio anticolinérgico
PT96857A (pt) Processo para a preparacao de oxetanonas
PT874853E (pt) Processo de preparacao de cefdinir
BRPI0414541A8 (pt) compostos heterocíclicos fundidos, seu uso, método de preparação de compostos intermediários e método para estudar distúrbios mediados por serotonina
DE69634667D1 (de) Boule-oscillationsmustern für die herstellung von geschmolzenem quarzglas
BR9803807A (pt) Processo para produção de protéina.
BR9909739A (pt) Benzotiadiazóis e derivados
BRPI9814894A (pt) processo para a preparação de ácidos 8-metóxi-quinolonocarboxílicos.
BR0016052A (pt) Processo para a preparação de cloridrato de epinastina na modificação de cristal de elevado ponto de fusão
BR0212772A (pt) Processo para a preparação de repaglinida
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
DK0748795T3 (da) Substituerede benzyloxycarbonylguanidiner som inhibitorer af Na+/H+-ombytningen, fremgangsmåde til deres fremstilling, dere
BR0115963A (pt) Derivados de benzofurano e benzotiofeno
BR0210664A (pt) Processo de sìntese técnico para produção de tropenol
BR0210410A (pt) Processo para produção do derivado de piperidina, fexofenadina
BR9811855A (pt) Processo para preparação de ácido l-ascórbico
PT828711E (pt) Novo processo para a preparacao de monohidrato de cloridrato de ropivacaina
BR9808642A (pt) Processo para preparar eprosartan
PT1399427E (pt) Processo para a preparacao de azoxistrobina a seus analogos
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
BR9808664A (pt) Processo para preparar eprosartan
ITMI20002187A0 (it) Processo per la produzione dell'acido r(+) -lipico
BR9810481A (pt) Processo para preparação de 1h-indol-3-glioxamidas 4-substituìdas.
BR9806875A (pt) Processo para a preparação de um composto.
BR0017175A (pt) Modificação da torasemida amorfa

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM O ART.34 "II" DA LPI (LEI 9279, DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.